$Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review$

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

BackgroundWe aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL).Research design and methodsWe searched eligible publications up to January 31s...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Linyan Tian, Cheng Li, Juan Sun, Yixin Zhai, Jinhuan Wang, Su Liu, Yanan Jiang, Wenqi Wu, Donghui Xing, Yangyang Lv, Jing Guo, Hong Xu, Huimeng Sun, Yuhang Li, Lanfang Li, Zhigang Zhao
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2023-01-01
coleção:	Frontiers in Immunology
Assuntos:	R/R DLBCL CAR-T cell auto-HSCT survival meta-analysis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1041177/full

Registros relacionados

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wenqi Wu, et al.
Publicado em: (2023-01-01)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wenqi Wu, et al.
Publicado em: (2023-06-01)

Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients
por: Kinga Krawiec, et al.
Publicado em: (2024-07-01)

Pretransplant hypoalbuminemia may be associated with poor survival in patients that underwent autologous hematopoietic stem cell transplantation (autoHSCT)
por: Serdar Sivgin, et al.
Publicado em: (2014-08-01)

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
por: Zhen Li, et al.
Publicado em: (2023-07-01)

Association of smoking with disease progression in persons with multiple sclerosis undergoing autologous hematopoietic cell transplantation: a single-center experience
por: Danitza Fernandez-Lara, et al.
Publicado em: (2024-01-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
por: Narendranath Epperla, et al.
Publicado em: (2025-01-01)

The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
por: Zhipeng Li, et al.
Publicado em: (2024-04-01)

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
por: Mishima Yuko, et al.
Publicado em: (2012-09-01)

Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
por: Fatemeh Riasi, et al.
Publicado em: (2023-12-01)

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
por: Qian Fan, et al.
Publicado em: (2016-11-01)

Evaluation of the Effects of R-CHOP Chemotherapy on Brain Glucose Metabolism in Patients with Diffuse Large B Cell Lymphoma: A Baseline, Interim, and End-of-Treatment PET/CT Study
por: Haiyan Zhu, et al.
Publicado em: (2022-10-01)

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Hong Xu, et al.
Publicado em: (2022-06-01)

Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
por: Wei Sang, et al.
Publicado em: (2020-08-01)

Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy
por: Mengya Cong, et al.
Publicado em: (2024-01-01)

Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature
por: N G GABEEVA, et al.
Publicado em: (2018-07-01)

MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8+ T lymphocytes in human diffuse large B cell lymphoma
por: Yangyang Xu, et al.
Publicado em: (2020-11-01)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Nan Yan, et al.
Publicado em: (2021-07-01)

Prognostic value of interim PET/CT in GCB and non-GCB DLBCL: comparison of the Deauville five-point scale and the ΔSUVmax method
por: Na Sun, et al.
Publicado em: (2024-12-01)

Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era
por: Wei‐Li Ma, et al.
Publicado em: (2024-01-01)

From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives
por: Elisaveta Voynova, et al.
Publicado em: (2021-10-01)

The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Epameinondas Koumpis, et al.
Publicado em: (2024-11-01)

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
por: Johanna Vets, et al.
Publicado em: (2023-04-01)

PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients
por: M V Solovev, et al.
Publicado em: (2019-07-01)

Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
por: Xiangxiang Zhou, et al.
Publicado em: (2020-06-01)

Primary Bone Marrow Diffuse Large B-Cell Lymphoma in a frail and older patient: long lasting remission by R-CHOP
por: Pasquale Niscola
Publicado em: (2014-08-01)

Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients
por: Wenyu Zhao, et al.
Publicado em: (2024-02-01)

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
por: Pellegrino Musto, et al.
Publicado em: (2024-08-01)

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
por: Chen Yang, et al.
Publicado em: (2018-10-01)

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma
por: Antonin Bouroumeau, et al.
Publicado em: (2021-11-01)

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma
por: Karolina Piechna, et al.
Publicado em: (2022-10-01)

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix
por: Hiroko Murata, et al.
Publicado em: (2020-08-01)

Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study
por: Danqi Luo, et al.
Publicado em: (2024-04-01)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Yanan Jiang, et al.
Publicado em: (2022-06-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
por: Gohar S. Manzar, et al.
Publicado em: (2025-01-01)

Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation
por: Ying Jiang, et al.
Publicado em: (2024-04-01)

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT
por: Ulrike Bacher, et al.
Publicado em: (2023-04-01)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
por: Kristina Sonnevi, et al.
Publicado em: (2021-11-01)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
por: Jiaqi Cui, et al.
Publicado em: (2022-09-01)

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
por: Guido Lancman, et al.
Publicado em: (2018-01-01)